These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 14730504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
    Goodman WG.
    Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunoassays for the detection of parathyroid hormone.
    Jüppner H, Potts JT.
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute and chronic regulation of circulating PTH: significance in health and in disease.
    D'Amour P.
    Clin Biochem; 2012 Aug; 45(12):964-9. PubMed ID: 22569597
    [Abstract] [Full Text] [Related]

  • 11. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T, Sci B.
    Nefrologia; 2003 Aug; 23 Suppl 2():69-72. PubMed ID: 12778858
    [Abstract] [Full Text] [Related]

  • 12. Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy.
    Godber IM, Parker CR, Lawson N, Hitch T, Porter CJ, Roe SD, Cassidy MJ, Hosking DJ.
    Ann Clin Biochem; 2002 May; 39(Pt 3):314-7. PubMed ID: 12038608
    [Abstract] [Full Text] [Related]

  • 13. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.
    Divieti P, John MR, Jüppner H, Bringhurst FR.
    Endocrinology; 2002 Jan; 143(1):171-6. PubMed ID: 11751606
    [Abstract] [Full Text] [Related]

  • 14. New PTH assays and renal osteodystrophy.
    Salusky IB, Jüppner H.
    Pediatr Nephrol; 2004 Jul; 19(7):709-13. PubMed ID: 15173936
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands.
    Murray TM, Rao LG, Divieti P, Bringhurst FR.
    Endocr Rev; 2005 Feb; 26(1):78-113. PubMed ID: 15689574
    [Abstract] [Full Text] [Related]

  • 18. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG.
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [Abstract] [Full Text] [Related]

  • 19. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.
    Andress DL, Endres DB, Maloney NA, Kopp JB, Coburn JW, Sherrard DJ.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1163-9. PubMed ID: 3760116
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone: what are we measuring and does it matter?
    Blumsohn A, Al Hadari A.
    Ann Clin Biochem; 2002 May; 39(Pt 3):169-72. PubMed ID: 12038589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.